✦ LIBER ✦

BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel

✍ Scribed by Lobna R. Ezz Elarab; Manal El Mahdy; Khaled Abdel Karim

Publisher: Springer
Year: 2010
Tongue: English
Weight: 437 KB
Volume: 9
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-010-0699-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect and side effects of Gemcitabi

The effect and side effects of Gemcitabine plus Vinorelbine in patients with triple-negative metastatic breast cancer

✍ Chen Yang; Zhiyu Wang; Yang Yao; Xiaojie Bian; Hui Zhao 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Serum EGFR and serum HER-2/neu are usefu

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy

✍ Maria Teresa Sandri; Harriet Ann Johansson; Laura Zorzino; Michela Salvatici; Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## BACKGROUND. Metronomic chemotherapy has been demonstrated to be of value in patients with advanced breast cancer. No reliable markers of response are available. In breast tumor, HER‐2/__neu__ is a prognostic factor, whereas no definite data exist for EGFR. The aim of the study was t